Dynamic immune response and its influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study

doi:10.4254/wjh.v18.i2.113004

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 2

This Article

(40)

(56)

(0)

(13)

(906)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Feb 27, 2026; 18(2): 113004
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.113004

Table 5 Linear trend analysis of lymphocyte subsets and their percentages in relation to clinical disease severity in coronavirus disease 2019 patients with non-alcoholic fatty liver disease

Variable	χ² value	P value
LY (cells/μL)	24.995	< 0.001
LY%	22.745	< 0.001
CD3+ (cells/μL)	24.038	< 0.001
CD3+CD4+ (cells/μL)	18.591	< 0.001
CD3+CD8+ (cells/μL)	17.564	< 0.001
CD3+%	0.545	0.461
CD3+CD4+%	0.031	0.861
CD3+CD8+%	0.051	0.822
CD4/CD8	0.108	0.742
CD19+ (cells/μL)	8.839	0.003
CD56+ (cells/μL)	5.444	0.02
CD19+%	0.165	0.685
CD56+%	1.404	0.236

LY: Lymphocyte counts.

Full Size Table

Citation: Yan P, Li R, Yuan XY, Wang Y, Lan LJ, Yu XP, Liu DF. Dynamic immune response and its influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study. World J Hepatol 2026; 18(2): 113004
URL: https://www.wjgnet.com/1948-5182/full/v18/i2/113004.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i2.113004

Yan P, Li R, Yuan XY, Wang Y, Lan LJ, Yu XP, Liu DF. Dynamic immune response and its influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study. World J Hepatol 2026; 18(2): 113004 [PMID: 41809480 DOI: 10.4254/wjh.v18.i2.113004]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.